Cantos G, Barbieri C L, Iacomini M, Gorin P A, Travassos L R
Department of Biochemistry, Federal University of Paraná, Curitiba, PR, Brazil.
Biochem J. 1993 Jan 1;289 ( Pt 1)(Pt 1):155-60. doi: 10.1042/bj2890155.
Antimony(Sb)-yeast mannan complexes were synthesized as a strategy to introduce Sb into macrophages infected with Leishmania amastigotes. The complexes were taken up by endocytosis after specific recognition by alpha-D-mannosyl receptors on the macrophage membrane. About 90% of the intracellular parasites were destroyed by Sb-mannan in vitro, whereas the corresponding Sb concentration used as the pentavalent antimonial drug glucantime destroyed about 60% of the amastigotes. None of the Sb complexes prepared with mannan acid or basic derivatives was as effective as the simple Sb-mannan complex in clearing macrophage infection by Leishmania (L) amazonensis. The leishmanicidal effect of Sb-mannan was also demonstrated in vivo with infected hamsters. The alternative use of Sb-mannan complex in the treatment of human leishmaniasis is envisaged on the basis of parasite-killing efficiency and the use of a low antimony dose.
合成了锑(Sb)-酵母甘露聚糖复合物,作为将锑引入感染利什曼原虫无鞭毛体的巨噬细胞的一种策略。复合物在被巨噬细胞膜上的α-D-甘露糖基受体特异性识别后通过内吞作用被摄取。体外,约90%的细胞内寄生虫被Sb-甘露聚糖破坏,而用作五价锑药物葡糖胺锑钠的相应锑浓度破坏了约60%的无鞭毛体。用甘露聚糖酸或碱性衍生物制备的Sb复合物在清除亚马逊利什曼原虫对巨噬细胞的感染方面均不如简单的Sb-甘露聚糖复合物有效。在感染的仓鼠体内也证实了Sb-甘露聚糖的杀利什曼原虫作用。基于杀寄生虫效率和低锑剂量的使用,设想将Sb-甘露聚糖复合物用于治疗人类利什曼病。